Evidence map›Paper›PMID 15706403›Full record

ArticleMolecular medicine (Cambridge, Mass.)

Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma.

Kostas Stamatopoulos, Chrysoula Belessi, Theodora Papadaki, Evangelia Kalagiakou, Niki Stavroyianni, Vassiliki Douka, Stavroula Afendaki, Riad Saloum, Aikaterini Parasi, Dimitra Anagnostou and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Kostas StamatopoulosHematology Department, G. Papanicolaou Hospital, Thessaloniki. Greece. stavstam@otenet.gr
Chrysoula Belessi
Theodora Papadaki
Evangelia Kalagiakou
Niki Stavroyianni
Vassiliki Douka
Stavroula Afendaki
Riad Saloum
Aikaterini Parasi
Dimitra Anagnostou
Nikolaos Laoutaris
Athanasios Fassas
Achilles Anagnostopoulos
G. Papanikolaou General Hospital · GRGeneral Hospital of Nikea · GREvangelismos Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The considerable heterogeneity in morphology, immunophenotype, genotype, and clinical behavior of splenic marginal zone lymphoma (SMZL) hinders firm conclusions on the origin and differentiation stage of the neoplastic cells. Immunoglobulin (IG) gene usage and somatic mutation patterns were studied in a series of 43 SMZL cases. Clonal IGHV-D-J rearrangements were amplified in 42/43 cases (4 cases carried double rearrangements). Among IGHV-D-J rearrangements, IGHV3 and IGHV4 subgroup genes were used with the highest frequency. Nineteen IGHV genes were unmutated (> 98% homology to the closest germline IGHV gene), whereas 27/46 were mutated. Clonal IGKV-J and IGLV-J gene rearrangements were amplified in 36/43 cases, including 31 IGKV-J (8/31 in lambda light-chain expressing cases) and 12 IGLV-J rearrangements; 9/31 IGKV and 6/12 IGLV sequences were mutated. IGKV-J and IGLV-J rearrangements used 14 IGKV and 9 IGLV different germline genes. Significant evidence for positive selection by classical T-dependent antigen was found in only 5/27 IGHV and 6/15 IGKV+IGLV mutated genes. These results provide evidence for the diverse B-cell subpopulations residing in the SMZ, which could represent physiologic equivalents of distinct SMZL subtypes. Furthermore, they indicate that in SMZL, as in other B cell malignancies, a complementarity imprint of antigen selection might be witnessed either by IGHV, IGKV, or IGLV rearranged sequences.

Indexed as

Complementarity Determining RegionsGene Rearrangement, B-Lymphocyte, Heavy ChainGene Rearrangement, B-Lymphocyte, Light ChainHumansImmunogeneticsImmunoglobulin Heavy ChainsImmunoglobulin kappa-ChainsImmunoglobulin Light ChainsLymphomaSomatic Hypermutation, ImmunoglobulinSplenic NeoplasmsComplementarity Determining RegionsImmunoglobulin Heavy ChainsImmunoglobulin kappa-ChainsImmunoglobulin Light Chains

Identifiers

PMID15706403
PMCPMC1431370
OpenAlexW2221604046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.